Literature DB >> 15731271

The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.

Marc C Johnson1, Jared L Spidel, Danso Ako-Adjei, John W Wills, Volker M Vogt.   

Abstract

Retroviral late domains (L domains) are short amino acid sequences in the Gag protein that facilitate the process of budding. L domains act by recruiting the ESCRT complexes, which normally function in the formation of multivesicular bodies. The PTAP late domain of human immunodeficiency virus (HIV) is believed to specifically recruit this machinery by binding the ESCRT protein TSG101. It was recently demonstrated that expression of a C-terminal fragment of TSG101 (TSG-3') blocked the budding of both PTAP-dependent and PPPY-dependent retroviruses. We show here that TSG-3' expression leads to the formation of large spherical entities that we call TICS (TSG-3'-induced cellular structures) in the cytoplasm. Rous sarcoma virus (RSV) and murine leukemia virus (MLV) Gag proteins are selectively recruited to these structures, but HIV type 1 Gag is completely excluded. Experiments with various HIV and RSV vector constructs as well as HIV and RSV chimeras suggest that recruitment to the TICS is late domain independent and does not involve recognition of any single amino acid sequence. TICS appear to have no limiting membrane and do not colocalize with markers for any membranous cellular compartment. Wild-type TSG101 is also recruited to TICS, but most other ESCRT proteins are excluded. These structures are similar in nature to aggresomes, colocalize with the aggresome marker GFP-250, and are highly enriched in ubiquitin but in other ways do not fully meet the description of aggresomes. We conclude that the block to retroviral budding by TSG-3' may be the result of its sequestration of Gag, depletion of free TSG101, or depletion of free ubiquitin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731271      PMCID: PMC1075695          DOI: 10.1128/JVI.79.6.3775-3786.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Aggresomes, inclusion bodies and protein aggregation.

Authors:  R R Kopito
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

2.  Ubiquitin is part of the retrovirus budding machinery.

Authors:  A Patnaik; V Chau; J W Wills
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

3.  Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.

Authors:  L Hermida-Matsumoto; M D Resh
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.

Authors:  S M Joshi; V M Vogt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  ATPase-defective mammalian VPS4 localizes to aberrant endosomes and impairs cholesterol trafficking.

Authors:  N Bishop; P Woodman
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

6.  Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells.

Authors:  A Kikonyogo; F Bouamr; M L Vana; Y Xiang; A Aiyar; C Carter; J Leis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

7.  Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).

Authors:  L VerPlank; F Bouamr; T J LaGrassa; B Agresta; A Kikonyogo; J Leis; C A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

8.  Repositioning basic residues in the M domain of the Rous sarcoma virus gag protein.

Authors:  E M Callahan; J W Wills
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2.

Authors:  U Schubert; D E Ott; E N Chertova; R Welker; U Tessmer; M F Princiotta; J R Bennink; H G Krausslich; J W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

10.  The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors.

Authors:  J Schaefer-Klein; I Givol; E V Barsov; J M Whitcomb; M VanBrocklin; D N Foster; M J Federspiel; S H Hughes
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

View more
  14 in total

1.  ESCRT-dependent targeting of plasma membrane localized KCa3.1 to the lysosomes.

Authors:  Corina M Balut; Yajuan Gao; Sandra A Murray; Patrick H Thibodeau; Daniel C Devor
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-18       Impact factor: 4.249

2.  Recruitment of the oncoprotein v-ErbA to aggresomes.

Authors:  Cornelius Bondzi; Abigail M Brunner; Michelle R Munyikwa; Crystal D Connor; Alicia N Simmons; Stephanie L Stephens; Patricia A Belt; Vincent R Roggero; Manohara S Mavinakere; Shantá D Hinton; Lizabeth A Allison
Journal:  Mol Cell Endocrinol       Date:  2010-11-12       Impact factor: 4.102

3.  The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101.

Authors:  Gisselle Medina; Yongjun Zhang; Yi Tang; Eva Gottwein; Marcy L Vana; Fadila Bouamr; Jonathan Leis; Carol A Carter
Journal:  Traffic       Date:  2005-10       Impact factor: 6.215

4.  Grp1-associated scaffold protein (GRASP) is a regulator of the ADP ribosylation factor 6 (Arf6)-dependent membrane trafficking pathway.

Authors:  Anand Venkataraman; Daniel J Nevrivy; Theresa M Filtz; Mark Leid
Journal:  Cell Biol Int       Date:  2012       Impact factor: 3.612

5.  The cellular factors Vps18 and Mon2 are required for efficient production of infectious HIV-1 particles.

Authors:  Yuriko Tomita; Takeshi Noda; Ken Fujii; Tokiko Watanabe; Yuko Morikawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

6.  Distinct Roles of Cellular ESCRT-I and ESCRT-III Proteins in Efficient Entry and Egress of Budded Virions of Autographa californica Multiple Nucleopolyhedrovirus.

Authors:  Qi Yue; Qianlong Yu; Qi Yang; Ye Xu; Ya Guo; Gary W Blissard; Zhaofei Li
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

7.  Functional replacement of a retroviral late domain by ubiquitin fusion.

Authors:  Anjali Joshi; Utpal Munshi; Sherimay D Ablan; Kunio Nagashima; Eric O Freed
Journal:  Traffic       Date:  2008-08-09       Impact factor: 6.215

8.  Molecular characterization of feline immunodeficiency virus budding.

Authors:  Benjamin G Luttge; Miranda Shehu-Xhilaga; Dimiter G Demirov; Catherine S Adamson; Ferri Soheilian; Kunio Nagashima; Andrew G Stephen; Robert J Fisher; Eric O Freed
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

9.  Mechanisms of late restriction induced by an endogenous retrovirus.

Authors:  Frederick Arnaud; Pablo R Murcia; Massimo Palmarini
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

10.  Defects in cellular sorting and retroviral assembly induced by GGA overexpression.

Authors:  Anjali Joshi; Kunio Nagashima; Eric O Freed
Journal:  BMC Cell Biol       Date:  2009-09-29       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.